LabCentral Houses Scientific Visionaries
Engaged in Early-Stage Research


VL49 is a platform technology pioneering the use of artificial intelligence and high-content datasets to develop novel therapeutics, based on strong foundational IP developed within the Flagship Pioneering innovation foundry. VL49 follows in the footsteps of VentureLabs companies such as Moderna Therapeutics, Seres Therapeutics, Rubius Therapeutics, and Evelo Therapeutics.

VL49 logo
Website - Coming Soon
  • Avak Kahvejian, PhD
  • Nicholas Plugis, PhD